Navigation Links
ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
Date:5/26/2011

z, an allergist/immunologist at the Allergy Clinic of Tulsa in Tulsa, Okla. "Raising awareness of rare disorders is critically important, and may help in the diagnosis of the disease. In addition, a film like this can help assure those dealing with such a rare condition that they are not alone."

This film is one in a series of programs that demonstrates ViroPharma's commitment to raising awareness of hereditary angioedema and to supporting the rare disease community. All of these programs – including Swell -- can be accessed at HAEandME.com.

About Hereditary Angioedema

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options.  Our goal is to pro
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
2. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
3. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
4. ViroPharma to Participate In Three May Healthcare Investor Conferences
5. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
6. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
7. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
8. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
9. ViroPharma Announces Securities Repurchase Program
10. ViroPharma to Participate in Two March Healthcare Conferences
11. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... DALLAS , July 3, 2015 ... report "Cardiac Monitoring & Cardiac Rhythm Management Market ... Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber ... published by MarketsandMarkets, the global Cardiac Monitoring (CM) ... poised to reach $26,646.5 Million by 2020 from ...
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... , July 2, 2015 ResMed Inc. (NYSE: ... fourth quarter and fiscal year ended June 30, 2015 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... SAN FRANCISCO , April 21, 2010 ... announced an agreement,with 100X Imaging, Inc. (100X Imaging) to develop and ... exclusive,rights to develop and market products based on this image indexing ... ...
... March 23 The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) based ... ... ... ...
Cached Medicine Technology:Strand to Develop and Market Breakthrough Software Solutions to Manage Insights Associated With Microscopy Images 2Novalung Records 50% Growth 2Novalung Records 50% Growth 3
(Date:7/4/2015)... ... ... Chronic Neck Pain. Neck pain is no small problem. NIH ... Another 19% suffer from head, migraine, or facial pain, in some cases related to ... workers must deal with neck pain. Strategies for mitigating neck pain range ...
(Date:7/3/2015)... ... ... Bank will hopefully be getting a large donation of canned food items at the ... are making it their mission to collect as many canned items as possible. Donations do ... public as well. As part of the canned food drive, these local chiropractors will be ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... speaker lineup for its 2015 Annual Conference , the premiere continuing ... at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include the ...
(Date:7/3/2015)... LENEXA, Kan. (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... have been known to cause momentary periods of blindness. ... how much information people can hold in their visual short-term ... miss visual images that pass right before our eyes when ... is not all. The new research indicates that we can ...
... the body from tissue damage also increases the risk ... University School of Medicine in St. Louis tested the ... survive the effects of toxic chemotherapeutic agents. ,They ... tumours in mice exposed to a carcinogen, reports the ...
... a deficient gene that is also responsible for the ... causes congenital blindness in children. The researchers’ study regarding ... is published in the August issue of the journal ... is lacking in these patients, by gene therapy should ...
... Kerala has claimed to have found a rat's tail in a ... 13, 2005) a soft drink from the Coca Cola Company.,There has ... to file a petition against // the company under the Prevention ... respond to the allegation. The allegation against Coke comes at a ...
... A new technique known as the Checkerboard Tissue Microarray ... of prostate cancer. ,Needle biopsies, blood ... determine how aggressive the cancer // is and whether ... tests are however not very accurate, resulting in thousands ...
... Johns Hopkins University School of Medicine had said in a ... of Medicine that the disease called Rocky Mountain spotted fever ... an outbreak. ,The research highlights the importance of the ... that could be traced back to ticks carried into to ...
Cached Medicine News:Health News:Enzyme Responsible For Congenital Blindness 2Health News:New advance in prostate cancer management 2Health News:Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts 2
Swedish Knee Cage -- hinged to track knee motion. Effective control of genu recurvatum (back knee or knee hyperextension). Fits left or right....
... Infrapatellar Band uses an aircell ... patellar tendon helping to relieve ... patella tendonitis. Focusing the pressure ... tubercle with less constriction of ...
Designed to provide continuous cold therapy to the shoulder and back. Helps to reduce pain and swelling and speed rehab....
... fusion, dislocation, reconstruction or soft tissue ... to be positioned in external, neutral ... injury this orthosis can be used ... healing process and can position the ...
Medicine Products: